• Liposomal Co-Delivery of Cisplatin and Procainamide Hydrochl

  2026-04-22

  This study demonstrates that co-encapsulation of cisplatin and procainamide hydrochloride in liposomal formulations potentiates antiproliferative effects in cancer cell lines while reducing cisplatin-induced toxicity. The findings provide a mechanistic and methodological framework for researchers seeking to optimize combinatorial drug delivery systems for oncology research.

• Vernakalant Hydrochloride: Strategic Insights for Translatio

  2026-04-21

  This thought-leadership article delivers a mechanistic and translational deep-dive into Vernakalant Hydrochloride (RSD1235) for rapid conversion of atrial fibrillation. It integrates population PK/PD modeling, ion channel selectivity, and workflow optimization, offering actionable strategies for researchers and clinicians aiming to maximize experimental rigor and translational impact.

• Temozolomide (SKU B1399): Reliable DNA Damage Induction in C

  2026-04-21

  This article explores common laboratory challenges in DNA damage and cytotoxicity assays, demonstrating how Temozolomide (SKU B1399) addresses reproducibility, solubility, and experimental sensitivity. Backed by peer-reviewed data and workflow guidance, it empowers biomedical researchers to leverage this small-molecule alkylating agent for robust DNA repair and chemotherapy resistance studies.

• Fumagillin: A Validated Methionine Aminopeptidase-2 Inhibito

  2026-04-20

  Fumagillin is a potent methionine aminopeptidase-2 inhibitor with well-documented effects on endothelial cell proliferation and angiogenesis. Multiple in vivo and in vitro studies confirm its efficacy in tumor-induced angiogenesis inhibition and antiparasitic applications. Key protocol parameters and evidence thresholds are clearly defined for translational research.

• A40926: Molecular Regulation & Next-Gen Glycopeptide Assay D

  2026-04-20

  Explore A40926, the potent dalbavancin precursor, through the lens of advanced molecular regulation and biosynthetic optimization. This in-depth guide offers unique insights into genetic control, assay parameters, and research applications that set it apart in Gram-positive bacterial infection research.

• EPZ-6438: Advanced Insights into EZH2 Inhibition and Transla

  2026-04-19

  Explore how EPZ-6438, a potent EZH2 inhibitor, drives breakthroughs in epigenetic cancer research and translational oncology. This article offers a unique perspective on assay optimization and real-world application, grounded in the latest scientific findings.

• Cy3 TSA Fluorescence System Kit: Amplified Detection in IHC

  2026-04-18

  Unlock unprecedented sensitivity in protein and nucleic acid detection with the Cy3 TSA Fluorescence System Kit. This advanced TSA fluorescence kit from APExBIO delivers robust signal amplification, empowering researchers to visualize low-abundance targets in immunohistochemistry, immunocytochemistry, and in situ hybridization workflows.

• Immunoproteasome Activation Primes TRIM5α for HIV-1 Restrict

  2026-04-17

  Jimenez-Guardeño et al. reveal that type I interferon triggers immunoproteasome activation, enabling human TRIM5α to restrict HIV-1 infection—contrary to prior assumptions of its inactivity. This study reframes the role of immunoproteasome dynamics in antiviral defense and suggests new avenues for immune modulation research.

• Prolonging Corneal Epithelial Cell Proliferation with 6C Med

  2026-04-16

  This study introduces a novel 6C cell culture medium that extends the proliferative activity of mouse corneal epithelial cells both in vitro and in vivo. By inhibiting epithelial-mesenchymal transdifferentiation via targeted small molecules—including IWP-2—the paradigm advances the generation of transplantable epithelial sheets and supports regenerative medicine research.

• Acute and Chronic Toxicity of Sulfamonomethoxine in Aquatic

  2026-04-15

  This study provides the first systematic evaluation of Sulfamonomethoxine (SMM) toxicity across multiple aquatic organisms, revealing differential sensitivities among trophic levels. The findings inform both environmental risk assessment and responsible antibiotic stewardship in veterinary and aquaculture contexts.

• Ganetespib (STA-9090): Systems-Level Impact on Hsp90 and Cel

  2026-04-14

  Explore how Ganetespib (STA-9090) enables next-generation cancer research by disrupting Hsp90-mediated chaperone networks and linking protein homeostasis to regulated cell death. This article delivers novel frameworks—bridging mechanistic insight and experimental design—that go beyond existing resources.

• HBsAg Suppresses IFN-I and Induces Early Autophagy via TBK1

  2026-04-13

  This study reveals that hepatitis B surface antigen (HBsAg) manipulates TANK-binding kinase 1 (TBK1) to simultaneously suppress type I interferon signaling and trigger early autophagy, undermining antiviral defenses. These findings delineate a mechanism by which HBV promotes persistent infection and highlight potential molecular targets for therapeutic intervention.

• EZ Cap™ Human PTEN mRNA: Driving mRNA Immunotherapy Innovati

  2026-04-12

  Explore how EZ Cap™ Human PTEN mRNA advances tumor suppressor gene mRNA research and unlocks new strategies in mRNA-based cancer immunotherapy. This article reveals innovations in delivery, translational efficiency, and immune activation that set this reagent apart.

• AP20187: Precision Chemical Inducer of Dimerization in Gene

  2026-04-12

  AP20187 empowers researchers to orchestrate conditional gene expression with high temporal and spatial fidelity. Its validated performance in fusion protein dimerization and growth factor receptor signaling activation makes it a cornerstone for regulated cell therapy and metabolic research.

• Alfuzosin HCl in Benign Prostatic Hyperplasia Research Workf

  2026-04-11

  Alfuzosin HCl enables precise, high-throughput quantification and functional analyses in benign prostatic hyperplasia research. New spectrophotometric approaches and robust in vitro parameters allow researchers to dissect α1-adrenergic receptor signaling with exceptional clarity, minimizing cardiovascular confounders and boosting reproducibility.

455 records 21/31 page Previous Next First page 上5页 2122232425 下5页 Last page